Remove Magazine Remove Pharmaceutical Companies Remove Pharmaceutical Manufacturing
article thumbnail

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. “Great thanks to Pharmaceutical Technology.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Large pharmaceutical companies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. billion) of these deals.

article thumbnail

Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Drugmakers have poured billions of dollars into pharma manufacturing facilities across the US as they adapt to macroeconomic pressures. Tomas Ragina via Shutterstock.